PTPRC and colitis: To further test this, we probed the same cohort of Bmal1+/+ control and Bmal1-/- mutant mice for immune system blood cells (marked by anti-CD45) (Pilling et al., 2009) which infiltrate tissue lesions during DSS-induced colitis (Figure 6F).